-57%

est. 2Y upside i

HealthcareSeries B

Rank

#1073

Sector

Healthtech, Beauty & Skincare

Est. Liquidity

~4Y

Data Quality

Data: Low

GetHarley presents a moderate upside opportunity for a job seeker, driven by its strong triple-digit growth in a large and expanding healthtech and beauty market.

Last updated: March 10, 2026

Bull (30%)+300%

GetHarley successfully leverages its curated clinician network and expands its product offerings, including supplements and new consultation categories, to capture significant market share in both medical-grade skincare and teledermatology. This drives annual revenue to over $150M by 2028, justifying a $1.2B valuation at 8x+ revenue, fueled by strong brand loyalty and network effects.

Base (35%)+50%

GetHarley maintains strong growth, expanding its clinician network and patient base, but faces increasing competition from well-funded direct competitors like Skin + Me and larger telehealth players such as Hims & Hers. Revenue reaches $70M-$80M by 2028, leading to an acquisition or next funding round at a $450M valuation, providing a solid but not explosive return.

Bear (35%)-70%

Intense competition from well-funded players like Hims & Hers and Skin + Me, coupled with potential regulatory hurdles or slower-than-expected market adoption, stifles GetHarley's growth. Revenue stalls below expectations, leading to a down round or distressed acquisition at a $90M valuation, significantly eroding common stock value due to liquidation preferences.

Est. time to liquidity~3.5 years

Preference Stack Risk

high

Investors hold $67M in liquidation preferences ahead of common stock, representing 22.3% of the estimated $300M current valuation.

Dilution Risk

moderate

As a Series B company, GetHarley will likely undergo at least one to two more funding rounds (Series C, D) before a liquidity event, leading to further dilution for existing equity holders.

Secondary Liquidity

none

There is no indication of active secondary markets or tender offers for GetHarley's equity at this stage.

Other — 1 role

View all 1 open roles at GetHarley →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on GetHarley's data — designed to show you've done your homework.

  • 1

    “Given the strong competition from players like Skin + Me in personalized prescription skincare and the broad reach of Hims & Hers in telehealth, how does GetHarley plan to maintain and expand its competitive moat, particularly regarding its curated clinician network and integrated platform?”

  • 2

    “With reported triple-digit annual growth and a hybrid revenue model, what are the key drivers for scaling revenue to the next $100M, and how do you foresee the balance between consultation fees and product sales evolving over the next 2-3 years?”

  • 3

    “As a Series B company that has raised $67M, what is the anticipated timeline for future funding rounds or a liquidity event (e.g., IPO or acquisition), and how does the company plan to manage potential dilution for employees holding equity?”

Community

Valuation Sentiment

Our model estimates -57% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.